Suppr超能文献

原癌基因激酶Pim1的晶体结构:弥漫性大细胞淋巴瘤中异常体细胞超突变的一个靶点

Crystal structures of proto-oncogene kinase Pim1: a target of aberrant somatic hypermutations in diffuse large cell lymphoma.

作者信息

Kumar Abhinav, Mandiyan Valsan, Suzuki Yoshihisa, Zhang Chao, Rice Julie, Tsai James, Artis Dean R, Ibrahim Prabha, Bremer Ryan

机构信息

Plexxikon, Inc., 91 Bolivar Drive, Berkeley, CA 94710, USA.

出版信息

J Mol Biol. 2005 Apr 22;348(1):183-93. doi: 10.1016/j.jmb.2005.02.039.

Abstract

Pim1, a serine/threonine kinase, is involved in several biological functions including cell survival, proliferation, and differentiation. While pim1 has been shown to be involved in several hematopoietic cancers, it was also recently identified as a target of aberrant somatic hypermutation in diffuse large cell lymphoma (DLCL), the most common form of non-Hodgkin's lymphoma. The crystal structures of Pim1 in apo form and bound with AMPPNP have been solved and several unique features of Pim1 were identified, including the presence of an extra beta-hairpin in the N-terminal lobe and an unusual conformation of the hinge connecting the two lobes of the enzyme. While the apo Pim1 structure is nearly identical with that reported recently, the structure of AMPPNP bound to Pim1 is significantly different. Pim1 is unique among protein kinases due to the presence of a proline residue at position 123 that precludes the formation of the canonical second hydrogen bond between the hinge backbone and the adenine moiety of ATP. One crystal structure reported here shows that changing P123 to methionine, a common residue that offers the backbone hydrogen bond to ATP, does not restore the ATP binding pocket of Pim1 to that of a typical kinase. These unique structural features in Pim1 result in novel binding modes of AMP and a known kinase inhibitor scaffold, as shown by co-crystallography. In addition, the kinase activities of five Pim1 mutants identified in DLCL patients have been determined. In each case, the observed effects on kinase activity are consistent with the predicted consequences of the mutation on the Pim1 structure. Finally, 70 co-crystal structures of low molecular mass, low-affinity compounds with Pim1 have been solved in order to identify novel chemical classes as potential Pim1 inhibitors. Based on the structural information, opportunities for optimization of one specific example are discussed.

摘要

Pim1是一种丝氨酸/苏氨酸激酶,参与多种生物学功能,包括细胞存活、增殖和分化。虽然Pim1已被证明与多种造血系统癌症有关,但最近它也被确定为弥漫性大细胞淋巴瘤(DLCL,非霍奇金淋巴瘤最常见的形式)中异常体细胞超突变的靶点。已解析了无配体形式以及与AMPPNP结合的Pim1的晶体结构,并确定了Pim1的几个独特特征,包括在N端叶中存在一个额外的β-发夹以及连接酶的两个叶的铰链的异常构象。虽然无配体的Pim1结构与最近报道的结构几乎相同,但与Pim1结合的AMPPNP的结构却有显著差异。由于在第123位存在一个脯氨酸残基,Pim1在蛋白激酶中是独特的,该残基阻止了铰链主链与ATP腺嘌呤部分之间形成典型的第二个氢键。这里报道的一个晶体结构表明,将P123突变为甲硫氨酸(一种能为ATP提供主链氢键的常见残基)并不能将Pim1的ATP结合口袋恢复到典型激酶的状态。如共结晶学所示,Pim1中的这些独特结构特征导致了AMP和一种已知激酶抑制剂支架的新型结合模式。此外,还测定了在DLCL患者中鉴定出的五个Pim1突变体的激酶活性。在每种情况下,观察到的对激酶活性的影响与突变对Pim1结构的预测结果一致。最后,已解析了70个低分子量、低亲和力化合物与Pim1的共晶体结构,以鉴定作为潜在Pim1抑制剂的新型化学类别。基于结构信息,讨论了优化一个具体实例的机会。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验